Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.
Clinical trial NCT04061109 · UNKNOWN
Trial details
- NCT number
- NCT04061109
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2020-03-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.